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Abstract  
Purpose: Both the Fatigue Severity Scale (FSS), it’s abbreviated version the FSS7, and the Checklist Individual 
Strength (CIS-20r), especially it’s subscale fatigue severity (CIS-f), are used in stroke patients to measure 
fatigue. However neither scale was developed for this population.This study sought to examine the 
psychometric properties and the underlying constructs of these scales to help the clinician and/or researcher in 
their choice of instrument.  
Methods: The FSS and the CIS-20r were administered to 239 stroke patients and 128 age matched healthy 
controls.  
Results: Both (sub) scales were able to discriminate at scale and at item level between patients and healthy 
controls, except items 1 and 2 of the FSS, leaving the FSS7. The internal consistency was high for the FSS7 and 
the CIS-f (Cronbach’s α:  FSS7 = .87; CIS-f = .88). The convergent validity (Pearson Correlation) between the 
(sub) scales ranged from r=.47 in patients to r=.80 in healthy controls. Principal Axis Factoring analysis on all 
items of the FSS7 and the CIS-f combined were conducted to investigate underlying constructs. FSS7 and CIS-f 
items loaded on different factors. In stroke patients these revealed three factors: “Experienced fatigue” (CIS-f 
items 1,2,3,4,5 and 7), “Fatigue impact” (all FSS7 items) and “Physical condition” (CIS-f items 6 and 8). 
Conclusions: The first two items of the original FSS do not aid in the measurement of fatigue in stroke patients 
and should thus be omitted in this population. The FSS7 and the CIS-f measure different constructs that 
correlate only moderately in stroke patients. Fatigue rating tools can thus not be used interchangeably. These 
differences must be taken into consideration when selecting one of these fatigue scales for either diagnostic or 
research purposes.  
 
Keywords: fatigue, stroke, psychometrics, symptoms, quality of life 
 
Resumo 
Objetivo: Tanto a Fatigue Severity Scale (FSS), na sua versão abreviada FSS7, e a Checklist Individual 
Strength (CIS-20r), sobretudo a sua subescala fatigue severity (CIS-f), são usadas em pacientes que tiveram um 
AVC para medir a fadiga. No entanto, nenhuma das escalas foi desenvolvida para esta população. Este estudo 
procurou analisar as propriedades psicométricas e os constructos subjacentes dessas escalas como forma de 
ajudar o clínico e/ou investigador na sua escolha do instrumento. Métodos: A FSS e a CIS-20r foram aplicadas 
a 239 pacientes com AVC e 128 sujeitos saudáveis da mesma faixa etária como grupo controle. Resultados: 
Ambas as sub-escalas eram capazes de discriminar ao nível da escala e ao nível do item entre paciente e sujeitos 
saudáveis no grupo controle, excepto os itens 1 e 2 da FSS, deixando o FSS7. A consistência interna foi alta 
para o FSS7 e para o CIS-f (Cronbach’s α: FSS7 = .87; CIS-f = .88). A validade convergente (Correlação de 
Pearson) entre as (sub) escalas variou entre r=.47 nos pacientes e r=.80 no grupo controle. Foi levada a cabo 
uma análise factorial de eixo principal em todos os itens da FSS7 e da CIS-f combinados, visando investigar 
constructos subjacentes. Os itens da FSS7 e da CIS-f verificaram resultados em diferentes fatores. Nos pacientes 
com AVC verificaram-se 3 fatores: “Experiência de fadiga” (itens 1, 2, 3, 4, 5 e 7 da CIS-f), “Impacto da 
fadiga” (todos os itens da FSS7) e “Condição física” (os itens 6 e 8 da CIS-f). Conclusão: Os dois primeiros 
itens da versão original da FSS não auxiliaram na medição da fadiga em pacientes com AVC e devem ser 
omitidos para esta população A FSS7 e a CIS-f medem diferentes constructos que se correlacionam apenas 
moderadamente nos pacientes com AVC. As ferramentas de avaliação da fadiga não podem, no entanto, ser 
usados alternadamente. Estas diferenças devem ser tidas em consideração aquando da seleção de uma dessas 
escalas para avaliação da fadiga, tanto para efeitos de diagnóstico como para efeitos de investigação. 
Palavras-chave: fadiga, AVC’c, psicometria, sintomas, qualidade de vida
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Introduction 
Post stroke fatigue (PSF) is 
generally defined as ‘a subjective 
experience of extreme and persistent 
tiredness, weakness or exhaustion after 
stroke, which can present itself mentally, 
physically or both and which is unrelated 
to previous exertion levels’ (Staub & 
Bogousslavsky, 2001a). PSF is a common 
and debilitating complaint (Barrit & 
Smithard, 2011; Lerdal et al., 2009; Staub 
& Bogousslavsky, 2001a) with prevalence 
rates ranging from 38% to 77% (Lerdal et 
al., 2009). Even after a minor stroke or a 
transient ischemic attack, fatigue has been 
reported in 23% to 40% of the patients 
(Moran et al., 2014). PSF has been found 
to severely impact quality of life 
(Carlsson, Moller, & Blomstrand, 2003; 
van de Port, Kwakkel, Schepers, 
Heinemans, & Lindeman, 2007) 
rehabilitation outcomes (Bendz, 2003) and 
even mortality (Glader, Stegmayr, & 
Asplund, 2002; Mead et al., 2011; Naess, 
Lunde, Brogger, & Waje-Andreassen, 
2012). PSF furthermore often co varies 
with several unfavorable symptoms after 
stroke such as depression, anxiety, 
physical impairments and sleep 
disturbances (Lerdal et al., 2009; Wu, 
Mead, Macleod, & Chalder, 2015; Zedlitz, 
Visser-Meily, Schepers, Geurts, & Fasotti, 
2011). The wide variety in prevalence 
rates found may be partly due to different 
definitions and measures of PSF used.  
Unfortunately, a “golden standard” 
for the assessment of PSF is presently 
unavailable given the absence of valid 
biological markers (Barrit & Smithard, 
2011; Kutlubaev, Duncan, & Mead, 2011). 
Fatigue can therefore only be measured at 
a subjective level which is mostly done by 
self-report measures (Lerdal et al., 2009).  
As the use of a uniform definition of PSF 
is still lacking (Wu et al., 2015), 
assessment tools may differ in the concept 
they measure (Visser-Keizer, Hogenkamp, 
Westerhof-Evers, Egberink, & Spikman, 
2015; Zedlitz et al., 2011). Currently many 
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different assessment tools and cut-off 
scores are in use (Dittner, Wessely, & 
Brown, 2004; Whitehead, 2009; Wu et al., 
2015), posing challenges to researchers 
when comparing data and to clinicians 
when assessing a patient’s condition. This 
is especially pertinent since most fatigue 
rating scales were not developed for nor 
validated for stroke patients (Mead et al., 
2007; Visser-Keizer et al., 2015).  
Even though recently three fatigue 
scales especially for stroke have been 
developed (the Dutch Multidimensional 
Fatigue Scale (Visser-Keizer et al., 2015; 
Visser-Keizer, Hogenkamp, Westerhof-
Evers, & Schönherr, 2012), the Fatigue 
Scale for Motor and Cognitive Functions 
(FSMC) (Hubacher et al., 2012), and the 
Neurological Fatigue Index for Stroke 
(Mills et al., 2012)) these are not widely 
being used in clinical and/or research 
settings yet.  
The current study thus focusses on 
two widely used self-report scales used to 
assess PSF, the Fatigue Severity Scale 
(FSS) (Krupp, LaRocca, Muir-Nash, & 
Steinberg, 1989) and the Checklist 
Individual Strength (CIS-20r) (Vercoulen, 
Alberts, & Blijenberg, 1999; Vercoulen et 
al., 1994). These two questionnaires are 
still in wide use, not only because of their 
familiarity but also because the data are 
easily comparable to the vast body of 
available empirical data. 
The FSS is a nine-item one-
dimensional scale, originally developed to 
assess fatigue complaints after systemic 
lupus erythematosus and in multiple 
sclerosis (Krupp et al., 1989). Later it has 
also been used to measure fatigue in other 
neurological conditions, such as Traumatic 
Brain Injury (TBI) and stroke (Belmont, 
Agar, & Azouvi, 2009; Ziino & Ponsford, 
2005). Currently it is one of the most 
frequently used scales to assess PSF 
(Dittner et al., 2004; Lerdal et al., 2009; 
Whitehead, 2009). The average score on 
the FSS is most often utilized to assess 
fatigue severity in stroke patients (Dittner 
et al., 2004; Valko, Bassetti, Bloch, Held, 
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& Baumann, 2008), although the FSS was 
intentionally designed to reflect the impact 
of fatigue on daily life in persons with 
suspected fatigue (Dittner et al., 2004; 
Johansson, Kottorp, Lee, Gay, & Lerdal, 
2014; Krupp et al., 1989; Lerdal, Kottorp, 
et al., 2011). Available psychometric 
properties include a Cronbach’s alpha of 
.88-.93  and a retest intra class correlation 
of .76-.80 (Koopman, Brehm, Heerkens, 
Nollet, & Beelen, 2014; Rietberg, Van 
Wegen, & Kwakkel, 2010; Schwartz, 
Jandorf, & Krupp, 1993; Valko et al., 
2008). Different cut of scores for PSF have 
been reported, ranging between a mean 
score of 4 and 5 (total range: 1-7) (Dittner 
et al., 2004; Whitehead, 2009). 
Furthermore, Rash analyses in patients 
with Human Immunodeficiency Virus 
(HIV), Multiple Sclerosis and stroke have 
revealed that the first two items should be 
excluded from calculation since they 
diminish the psychometric properties of 
the scale (Johansson et al., 2014; Lerdal, 
Johansson, Kottorp, & von Koch, 2011; 
Mills, Young, Nicholas, Pallant, & 
Tennant, 2009).   
The CIS-20r is a 20-item 
multidimensional scale, which assesses 
four dimensions of fatigue on different 
subscales: fatigue severity, concentration 
problems, reduced motivation and reduced 
physical activity level (Vercoulen et al., 
1999; Vercoulen et al., 1994).  The tool 
was originally developed to assess chronic 
fatigue syndrome (Vercoulen et al., 1994). 
Since then the CIS-20r has become the list 
of choice in studies of fatigue in the 
Netherlands and in Belgium also for use in 
neurological conditions, such as TBI 
(Stulemeijer et al., 2006), brain tumor 
(Struik et al., 2009), multiple sclerosis and 
stroke (Snaphaan, Van der Werf, & De 
Leeuw, 2010; van der Werf, van den 
Broek, Anten, & Bleijenberg, 2001; 
Zedlitz, Rietveld, Geurts, & Fasotti, 2012).  
Reported Cronbach’s alpha values lie 
between 0.90 and 0.93 and retest intra 
class correlation of 0.81- 0.85 have been 
reported showing good internal 
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consistency and retest reliability  (Dittner 
et al., 2004; Koopman et al., 2014; 
Rietberg et al., 2010). Although the total 
score of the CIS-20r has  been reported to 
reflect fatigue severity in non-neurological 
patients (Beurskens et al., 2000), in 
patients with stroke, only the CIS- fatigue 
severity subscale (CIS-f) is used to assess 
the severity of experienced fatigue 
(Snaphaan et al., 2010; van der Werf et al., 
2001; Zedlitz, Rietveld, et al., 2012; 
Zedlitz et al., 2011).  This subscale 
consists of eight items and the cut-off for 
severe fatigue is generally set at a total 
score of either 35 or 40 (total range; 8-56) 
(Snaphaan et al., 2010; Stulemeijer et al., 
2006; van der Werf et al., 2001; Zedlitz, 
Rietveld, et al., 2012). A point of critique 
made by Staub and Bogouslavsky (2001) 
regarding this subscale is that it mainly 
assesses physical fatigue and not so much 
mental fatigue (Staub & Bogousslavsky, 
2001b). As patients can suffer from either 
or both aspects (Zedlitz, van Eijk, Kessels, 
Geurts, & Fasotti, 2012) this might, if 
proven true, have consequences for 
correctly diagnosing patients.  
Great benefits of both the FSS as 
well as the CIS-f scale are that they are 
short, simple to administer, and that the 
outcomes are easily compared to the many 
other studies using the same tool. However 
neither tool has been specifically designed 
for PSF (Dittner et al., 2004; Lerdal et al., 
2009; Mead et al., 2007) and only few 
studies have focused on the reliability and 
validity of these measures in stroke 
patients. Together with the subjective 
nature of fatigue and its many different 
aspect, this gap in previous research poses 
difficulties to both researchers and 
clinicians in describing and assessing a 
patient’s condition after stroke (Lerdal et 
al., 2009; van de Port et al., 2007). Both 
the FSS and the CIS-f are utilized to 
measure fatigue severity (Dittner et al., 
2004; Krupp et al., 1989; Lerdal et al., 
2009) and to detect changes in fatigue over 
time (Vercoulen et al., 1994; Whitehead, 
2009). However, at face value, they seem 
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to measure different constructs. In stroke 
patients they have been found to correlate 
with different psychological and 
neurological variables (Zedlitz et al., 
2011). In this perspective, the aim of the 
present paper is to first examine the 
psychometric properties of the (one-
dimensional) FSS and the (multi-
dimensional) CIS-20r in both stroke 
patients and healthy controls. Furthermore 
this study sought to examine the 
underlying constructs and the convergent 
validity of the FSS and the CIS scale. 
Taken together with the knowledge of the 
psychometric properties in stroke patients 
this could help the clinician and/or 
researcher in their choice of instrument.. 
Methods 
Participants and procedure 
Data were obtained from stroke 
patients who entered a study assessing the 
effectiveness of Cognitive and Graded 
Activity Training (COGRAT) on post-
stroke fatigue (N=83) (Zedlitz, Rietveld, et 
al., 2012), and by additional recruitment in 
three different rehabilitation centers (N= 
156). In the COGRAT study the inclusion 
criteria were (1) being aged between 18 
and 70 years; (2) suffering from severe 
fatigue (CIS-f ≥ 40) (Vercoulen et al., 
1994) (3) no severe cognitive deficits as 
assessed with the Rivermead Behavioural 
Memory Test (screening score>8; (Wilson, 
Cockburn, Baddeley, & Hiorns, 1989)), 
the Token Task (score>12; (Heesbeen & 
Van Loon-Vervoorn, 2001)) and the 
Behavioural Assessment of the 
Dysexecutive Syndrome (Wilson, 
Alderman, Burgess, Emslie, & Evans, 
1996) < borderline,  (4) not having co-
morbid depression as assessed with the 
Hospital Anxiety and Depression Scale 
(Zigmond & Snaith, 1983) (Depression 
score > 10, and a clinical interview when 
the score was 8-10 (MINI) (Sheehan et al., 
1998), (5) absence of severe pulmonary or 
cardiac disease and (6) being able to walk 
independently. The additional 156 
patient’s selection was based on age (over 
18 years of age), the presence of a stroke, 
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living independently, and the ability to 
complete the questionnaires 
autonomously. For all patients, age, level 
of education and time since stroke were 
recorded. Of the combined patient sample 
21 were excluded due to possible 
depression and 20 due to too severe 
cognitive deficits.  
Furthermore, the present study 
included 129 age-matched healthy 
controls. These were contacted through 
acquaintances of the researchers. We 
attempted to obtain a representative 
control group to the patient group with an 
equal distribution of different age 
categories and educational status and 
common ailments as they also occur in 
stroke patients. All participants were asked 
about their current health prior to 
participating. We then excluded subjects 
with diagnosed neurological disease, 
depression, advanced cancer or severe 
pulmonary and cardiac disease as these 
disorders cause fatigue. 
 
Questionnaires 
The Fatigue Severity Scale (FSS) is 
a one-dimensional scale which consists of 
nine items that are scored on a 7-point 
Likert scale, ranging from 1 (strongly 
disagree) to 7 (strongly agree). The fatigue 
score is calculated by means of nine item 
scores (range 1-7), with higher scores 
indicating higher levels of fatigue (Krupp 
et al., 1989). In this study the dutch, 
validated, version of the FSS was used 
(Koopman et al., 2014; Rietberg et al., 
2010)  
The Checklist Individual Strength 
(CIS-20r) is a 20-item questionnaire 
designed to measure four aspects of fatigue 
during the previous two weeks: fatigue 
severity (CIS-f: 8 items), concentration 
problems (5 items), reduced motivation (4 
items) and reduced physical activity level 
(3 items). Each item is scored on a 7-point 
Likert scale ranging from 1 (yes, that is 
true) to 7 (no, that is not true) (Vercoulen 
et al., 1999; Vercoulen et al., 1994). In this 
study we focused specifically on the 
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fatigue severity subscale (CIS-f) to 
measure PSF (range 8-56), because this 
subscale is more often used as a measure 
of fatigue severity than the subscales of the 
CIS-20r together in neurological patients. 
The CIS-20r originates from the 
Netherlands, we thus used the original, 
validated, version (Vercoulen et al., 1999). 
 
Statistical Analysis 
To compare the demographical and 
fatigue data of our groups, t-tests were 
used for interval and Chi-square-test for 
categorical variables. Then, Principal Axis 
Factoring (PAF) analysis with direct 
Oblimin Rotation was performed on the 
FSS and subsequently on all CIS-20R 
items obtained from the stroke patients to 
determine the construct validity of the FSS 
and the four subscales of the CIS-20Rfor 
this particular group. To investigate group 
differences in the FSS and the CIS-20r 
subscales, independent samples t-test were 
performed on scale and item levels. As 
previous studies strongly suggest the 
exclusion of the first two items (Johansson 
et al., 2014; Lerdal, Johansson, et al., 
2011; Mills et al., 2009) analyses were 
performed on the 9-item and on the 7-item 
(FSS7) version of the FSS.  
The internal consistency was 
calculated using Cronbach’s alpha, and 
Pearson’s correlation coefficient was 
computed to specify the convergent 
validity between the FSS and the CIS-f. 
Differences between the patient and 
control group were calculated by 
converting the correlation coefficients into 
z-scores, and determining the difference 
(zdiff) with the accompanying p value.  
To compare our data to the 
prevalence rates of post-stroke fatigue 
presented in the literature, we counted the 
number of respondents who scored above 
4 and 5 on the FSS, and those with higher 
scores than 35 and 40 on the CIS-f and 
calculated the convergence between the 
scales. 
To determine the dimensional 
properties of the scales, a PAF analysis 
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with direct oblimin rotation was performed 
on the item scores of the FSS and the CIS-
f for all subjects. This PAF analysis was 
then carried out for stroke subjects and 
healthy controls separately, to investigate 
construct validity across stroke patients 
and healthy controls. Factors were 
identified according to the following 
criteria: (1) the bend of the curve in the 
scree plot; (2) the amount of variance 
explained by the factors combined; (3) 
item loading of more than .4 on a factor; 
and (4) interpretability by the authors 
(Costello & Osborne, 2005). All analyses 
were performed using SPSS version 23 for 
Windows. 
 
Results 
Discriminatory analyses, internal 
consistency and concurrent validity of the 
FSS and the CIS-20r 
Demographical and scaled fatigue 
data of all participants are presented in 
table 1. Comparisons between patients and 
healthy controls revealed a significant 
difference (p>.05) in educational level 
(Table 1).  
 
Table 1.  
Demographical and scaled fatigue data of patients and healthy controls. 
Variable 
Patients 
N=239 
M (SD) 
 
Healthy 
controls 
N=128 
M (SD) 
 
 
 
 
t 
p 
95%  
Confidence 
Interval of 
the 
difference 
[lower, 
upper] 
Age, Mean (SD)  55.67 (8.96) 54.45 1.197 .232 [-78,  3.24 ] 
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(10.04) 
Gender, male (%)  51.9%  41.4% Χ2=3.664 .063  
Education (1-7),  
median (range) 5 (2-7) 
6 (2-7) Χ2=23.993 
<.001 
 
Years since stroke 3.82 (4.56)     
FSS7 5.05 (1.40) 
2.54 
(1.44) 
16.175 
<.001 
[2.20,  2.81] 
FSS 4.96 (1.26) 
2.91 
(1.25) 
14.651 
<.001 
[1.75,  2.29] 
CIS fatigue severity  
37.65 
(11.37) 
20.48 
(11.38) 
13.783 
<.001 
[14.72,  
19.62] 
CIS concentration 
problems  21.80 (8.11) 
11.70 
(6.92) 
12.527 
<.001 
[8.51,  11.69] 
CIS motivation  15.00 (6.37) 
9.83 
(4.95) 
8.052 
<.001 
[3.91,  6.44] 
CIS physical activity  12.26 (5.39) 
6.76 
(4.29) 
10.004 
<.001 
[4.42,  6.59] 
CIS-20r total score 
87.11 
(23.61) 
49.86 
(23.03) 
13.527 
<.001 
[31.84,  
42.67] 
 
 
 
Patients scored higher than healthy 
controls on the FSS and on all CIS-20r 
subscales (Table 1). The scores on the 
individual items of the FSS and CIS-20r 
are presented in table 2.  Analyses on scale 
and item level of the FSS and the CIS-20r 
revealed that patients differ significantly 
from the control group, save for item 2 of 
the FSS (Table 2). Furthermore the 95% 
Confidence interval (CI) of FSS item 1 lies 
below 1 point difference between groups 
and the lower bound of the 95% CI is 
below 1 for CIS-motivation items 1 and 3.   
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Table 2.  
Means of individual items of the FSS and CIS-20R.  
Items Patients  
 
N=239 
M (SD) 
Healthy 
controls 
N=128 
M (SD) 
 
 
 
t 
 
 
 
p 
 
95% CI - 
difference 
[lower, 
upper] 
FSS      
1. My motivation is lower when I am fatigued 5.38 (1.73) 4.99 (1.61) 2.127 .034 [.03,  .77] 
2. Exercise brings on my fatigue 3.59 (2.07) 3.38 (1.84) .983 .326 [-.21,  .62] 
3. I am easily fatigued 5.23 (1.80) 2.57 (1.72) 13.676 <.001 [2.27,  3.04] 
4. Fatigue interferes with my physical functioning 5.21 (1.74) 3.52 (2.01) 8.016 <.001 [1.27,  2.10] 
5. Fatigue frequently causes problems for me 4.10 (1.90) 2.15 (1.61) 10.323 <.001 [1.58,  2.32] 
6. My fatigue prevents sustained physical 
functioning 
4.59 (2.12) 2.20 (1.66) 11.869 <.001 [2.00,  2.78] 
7. Fatigue interferes with carrying out certain 
duties and responsibilities 
5.37 (1.83) 2.88 (2.00) 12.002 <.001 [2.08,  2.90] 
8. Fatigue is among my three most disabling 
symptoms 
5.76 (1.81) 2.43 (1.92) 16.435 <.001 [2.93,  3.73] 
9. Fatigue interferes with my work, family, or 
social life 
5.11 (1.92) 2.05 (1.65) 15.986 <.001 [2.69,  3.44] 
 
CIS-20R 
     
CIS-fatigue severity      
1. I feel tired 5.10 (1.86) 2.77 (1.94) 11.274 <.001 [1.93,  2.74] 
2. Physically I feel exhausted 4.31 (1.96) 2.26 (1.84) 9.959 <.001 [1.65,  2.46] 
3. I feel fit (reversed) 4.74 (1.82) 2.48 (1.60) 12.245 <.001 [1.89,  2.61] 
4. I feel weak 3.68 (2.05) 1.90 (1.39) 9.846 <.001 [1.42,  2.14] 
5. I feel rested (reversed) 5.00 (1.88) 3.02 (1.85) 9.679 <.001 [1.58,  2.38] 
6. Physically I feel I am in a bad condition 4.20 (2.05) 2.36 (1.62) 9.419 <.001 [1.45,  2.22] 
7. I get tired very quickly 5.62 (1.82) 2.67 (1.90) 14.593 <.001 [2.55,  3.34] 
8. Physically I feel I am in good shape (reversed) 5.01 (1.91) 3.04 (1.86) 9.519 <.001 [1.56,  2.38] 
CIS- concentration problems      
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1. Thinking requires effort  4.12 (2.08) 2.14 (1.70) 9.211 <.001 [1.56,  2.41] 
2. When I am doing something , I can concentrate 
quite well (reversed) 
3.96 (2.02) 2.13 (1.47) 9.298 <.001 [1.44,  2.22] 
3. I can concentrate well (reversed) 4.31 (2.01) 2.30 (1.56) 9.926 <.001 [1.61,  2.41] 
4. I have trouble concentrating 4.58 (1.96) 2.40 (1.70) 10.375 <.001 [1.77, 2.60] 
5. My thoughts easily wander 4.88 (1.92) 2.94 (1.90) 8.644 <.001 [1.50, 2.40] 
CIS – motivation      
1. I feel very active (reversed) 4.27 (1.91) 3.59 (2.18) 2.770 .006 [.20,  1.17] 
2. I feel like doing all kinds of nice things 
(reversed) 
3.32 (1.93) 1.91 (1.38) 7.567 <.001 [1.04,  1.77] 
3. I am full of plans (reversed) 3.48 (2.03) 2.36 (1.54) 5.559 <.001 [.73,  1.52] 
4. I feel no desire to do anything 3.93 (2.07) 1.97 (1.44) 9.935 <.001 [1.57,  2.35] 
CIS- physical activity      
1. I do quite a lot within a day (reversed)  3.98 (2.05) 2.43 (1.59) 7.543 <.001 [1.15,  1.96] 
2. I don’t do much during the day 3.90 (2.19) 2.09 (1.57) 8.552 <.001 [1.40,  2.23] 
3. I have a low output 4.38 (2.03) 2.24 (1.58) 10.459 <.001 [1.74,  2.55] 
 
A PAF analysis on all items of the FSS 
was conducted with congruent outcomes in 
the pattern matrix and structure matrix 
(rotation with Oblimin Kaiser 
Normalization converged in 4 iterations). 
The Kaiser –Meyer-Olkin (KMO) measure 
verified the sampling adequacy for the 
analysis (KMO= .86; ‘good’ according to 
Field (2009)). Two factors were identified. 
The first contained items 3 through 9 
(eigenvalue= 4.20, % of variance=46.69). 
The second factor solely consisted of item 
2 (eigenvalue=1.09, % of variance= 
12.11). Item 1 of the FSS did not load 
above .4 on any of the factors. The internal 
consistency of the 9 item FSS was .846. 
Cronbach’s α increased to .848 after 
deletion of item 1 and to .858 after 
deletion of item 2. With both items deleted 
(FSS7) α increased to 0.865. 
PAF analysis of the CIS20-R in 
stroke patients largely confirmed the 
separation of the items in the already 
existing four subscales (both in the pattern 
matrix and structure matrix; rotation with 
Oblimin with Kaiser Normalization 
converged in 10 iterations), fatigue 
severity (CIS-f; eigenvalue 7.32, % of 
variance 36.58, α=.882), concentration 
problems (eigenvalue 2.53, % of variance 
12.66, α=.869), reduced motivation 
(eigenvalue 1.80, % of variance 9.02, 
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α=.814), and reduced physical activity 
level (eigenvalue 1.39, % of variance 6.9, 
α=.820). Only the CIS-f item 8 loaded >.4 
on both the CIS-f subscale (.445) as on 
reduced motivation (.415). The KMO 
measure was .89, again verifying good 
sampling adequacy for the analysis (Field, 
2009). Therefore, the existing CIS-f 
subscale of the CIS-20r was used as an 
independent measure of fatigue severity in 
subsequent analyses. Within the subscales 
only deletion of Physical activity item 3 
resulted in a higher Cronbach’s α, from 
.820 to .826.  
Since items 1 and 2 of the FSS did 
not contribute to internal consistency nor 
to discriminatory value, the remaining 
FSS7 was used in subsequent analyses. 
The Pearson correlation (r) between CIS-f 
and FSS for all participants was .742 and 
between CIS-f and FSS7 it was .771 (both 
p<.001). The Pearson correlations for 
patients and healthy controls and the 
differences between groups are listed in 
table 3. The percentage of healthy controls 
scoring the FSS7 cut-off score of ≥ 4 was 
15.3% and 8.6% scored ≥ 5. In patients 
these percentages amounted to 77% and 
61.2% respectively. On the CIS-f 12.5% of 
the healthy controls scored above the cut-
off score ≥ 35, and 10.2% scored ≥ 40. The 
percentages for patients were 66.1% and 
52.7% respectively.  The congruency 
percentages of both scales of the groups 
combined are listed in table 4.   
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Table 3.  
Pearson correlations between CIS, FSS and FSS7. 
 R Patients R Healthy controls Zdiff Ptwo-tailed 
CIS-20R and FSS .497* .761* 4.11 <.001 
CIS-20R and FSS7 .472* .778* 4.78 <.001 
CIS-f and FSS .509* .770* 4.16 <.001 
CIS-f and FSS7 .545* .797* 4.34 <.001 
* p<.001 
 
Table 4.  
Congruency of cut-off scores between FSS7 and CIS-f 
 FSS7  
 below cut off 
score <4 
N (%) 
Between cut off 
scores  
≥4 and <5 
N (%) 
Above 
Cut off score ≥5 
 
N (%) 
Total 
 
N (%) 
CIS-f     
below cut off 
scores <35  
N (%) 
N=140 (38.14%) N=22 (5.99%) N=31 (8.45%) N=193 (52.59%) 
Between cut off 
scores  
≥35 and <40 
N (%) 
N=5 (1.36%) N=8 (2.18%) N=22 (5.99%) N=35 (9.54%) 
Above cut off score 
≥40 
N (%) 
N=12 (3.27%) N=18 (4.90%) N=109 (29.70%) N=139 (37.87%) 
Total 
N (%) 
N=157 (42.78%) N=48 (13.08%) N=162 (44.14%) N=367 (100%) 
Dimensional properties of the FSS7 and the CIS-fatigue severity subscale 
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Since the N to item ratios in 
patients (239: 15) and in healthy controls 
(128:15) were small, we chose to first 
analyze the data of both groups and then 
perform separate group analyses, to 
investigate whether the original factors of 
both scales would hold up. The analyses 
showed different results for the stroke 
patients compared to the healthy controls 
and both groups combined (see table 5). In 
the latter groups, two factors were 
identified after exploration of the scree 
plot, the amount of variance explained 
(>51%) and the initial eigenvalues. In the 
patient group, three factors were found. All 
PAF-analyses showed a distinction 
between the CIS-f and the FSS, with 
almost all items loading on factor 1 or 2 
respectively, indicating different 
underlying constructs. This difference was 
least clear in healthy controls, where FSS 
item 3 contributed to factor 1, and FSS 
items 8 and 9, loaded on both factors 1 and 
2. In stroke patients, a third factor was 
found consisting solely of CIS-f items 6 
and 8. The results of these PAF analyses 
with direct oblimin rotation are presented 
in table 5. 
 
Table 5.  
Principal axis factoring on FSS items and items of CIS-f in patients and healthy controls  
 
 Patients and Healthy 
controls (N=367) 
 Patients 
(N=239) 
 Healthy controls 
(N=128) 
Item Factor  Factor  Factor 
1 2  1 2 3  1 2 
CIS-f 1 .855   .850    .883  
CIS-f 2 .777   .677    .766  
CIS-f 3 .801   .522  .284  .859  
CIS-f 4 .826   .629    .762  
CIS-f 5 .783   .653    .817  
CIS-f 6 .703   .353  .604  .645  
CIS-f 7 .726   .799 .212   .810  
CIS-f 8 .554 -.215  .258  .511  .612  
FSS 3 .299 -.602  .253 .635   .783  
FSS 4  -.700   .557 .207   .742 
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FSS 5  -.746   .597    .692 
FSS 6  -.709   .597 .287   .630 
FSS 7  -.935   .813    .888 
FSS 8  -.790   .748 -.226  .451 .486 
FSS 9  -.853   .792   .367 .520 
Eigenvalues 9.12 1.25  6.48 1.94 1.07  9.00 1.24 
% of 
variance 
60.81  8.34   43.17 12.96 7.13  60.01 8.27 
 KMO= .947 
Rotation converged in 
5 iterations. 
 KMO= .882 
Rotation converged in 
9 iterations. 
 KMO= .921 
Rotation converged in 5 
iterations. 
 
Interpretation of the factors was based 
primarily on the analysis of the patient’s 
data, since both the FSS and the CIS-f are 
designed for patients suffering from 
fatigue, and the constructs seemed to differ 
between patients and healthy controls. 
Moreover, in stroke patients the 
intercorrelations between the factors were 
moderate at best, allowing the 
interpretation of different factors (factors 1 
and 2 r= .38; factors 1 and 3 r= .30: and 
factors 2 and 3 r=.28). 
Factor 1 consisted largely of items 
referring to the subjective feelings of 
weakness and tiredness in patients with 
stroke (CIS-f items 1: “I feel tired”; 2:  
 
“Physically I feel exhausted”; 3: “I 
feel fit (reversed)”; 4: “I feel weak”; 5: “I 
feel rested (reversed)”; and 7: “I get tired 
very quickly”). Therefore this factor was 
named “Experienced fatigue”.  Factor two 
consisted exclusively of all FSS items, 
covering the impact of fatigue on daily life 
functioning (see table 2 for all item 
content). Factor 3 referred to the CIS-f 
items (6 & 8) on physical fitness (CIS-f 
item 6: Physically I feel I am in a bad 
condition” and item 8:”physically I feel in 
a good shape”). Consequently this factor 
was named “Physical condition”. 
 
Discussion 
The present study sought to 
investigate the psychometric properties 
and concurrent validity of the FSS and the 
CIS-20r. It was found that the last 7 items 
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of the one-dimensional Fatigue Severity 
Scale (FSS7) and the multidimensional 
Checklist Individual Strength-20r (CIS-
20r) have good psychometric properties 
and adequately discriminate stroke patients 
with PSF from healthy controls. However, 
analyses of the (sub)scales that are claimed 
to measure fatigue severity, the FSS7 and 
the subscale “fatigue severity” of the 
CIS20-R (CIS-f), reveal that these scales 
assess different dimensions of fatigue in 
stroke patients. This is congruent with 
studies in patients with polio (Koopman et 
al., 2014) and MS (Rietberg et al., 2010) 
where different content of and only 
moderate associations between the lists 
were found. The FSS7 was found to assess 
the impact of fatigue on daily life 
functioning, whereas the CIS-f mostly 
reflected experienced fatigue. 
Furthermore, the convergent validity of 
both scales was only moderate in stroke 
patients. These results indicate that these 
assessment tools of PSF cannot be used 
interchangeably.  
Congruent with previous studies 
(Johansson et al., 2014; Lerdal, Johansson, 
et al., 2011; Lerdal, Kottorp, et al., 2011; 
Mills et al., 2009) it was found that the 
first two items of the original FSS did not 
aid in differentiation between patients and 
healthy controls and that they diminished 
the reliability of the scale. Most likely, 
these items are too generic to aid 
differentiation between pathological and 
normal fatigue. This confirms that in the 
administration of the FSS to stroke 
patients, these first two items should be 
eliminated, and that thus the remaining 
FSS7 should be used. The average score 
on the FSS(7) is most often utilized to 
assess fatigue severity in stroke patients 
(Dittner et al., 2004; Valko et al., 2008; 
Whitehead, 2009). However, the tool was 
originally designed to reflect the impact of 
fatigue on daily life in patients known to 
suffer from fatigue (Dittner et al., 2004; 
Krupp et al., 1989), a distinction that is not 
always recognized (Johansson et al., 2014; 
Whitehead, 2009). A previous study in 
stroke patients also found the FSS to 
correlate only moderately (r=.39) with 
VAS-scales asking about the experienced 
fatigue severity (Zedlitz, van Eijk, et al., 
2012). Moreover, none of the items of the 
FSS(7) ask about the severity of fatigue. 
Thus, taken together with the results of 
this study, it is questionable whether the 
FSS(7) is a valid scale for the assessment 
of fatigue severity in patients with stroke. 
The FSS7 does have its own merits 
though. It is a short, easy to administer 
self-rating tool, which assesses the impact 
of fatigue on the daily life of patients with 
stroke. 
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 The results of this study showed 
that most of the CIS-f items loaded on the 
factor “Experienced fatigue” albeit items 6 
and 8 that loaded more on “Physical 
condition”.  Even though we named the 
major factor of the CIS-f “experienced 
fatigue”, one could also argue that some of 
the items cover a physical component of 
fatigue, since some of the items stress 
fitness and weakness. This is in line with 
Staub and Bogousslavsky’s suggestion 
(Staub & Bogousslavsky, 2001b), that the 
CIS-f essentially assesses the physical 
component of fatigue. Furthermore, in a 
previous study in patients with severe 
post-stroke fatigue (Zedlitz et al., 2011) we 
found that the CIS-f showed a moderate 
association with somatic complaints, but 
not with cognitive symptoms. Although 
fatigue is often experienced both mentally 
as well as physically (Mills et al., 2012), a 
significant proportion experiences it as 
only physical feeling whereas a same 
proportion report only mental fatigue 
(Zedlitz, van Eijk, et al., 2012). Patients 
with predominantly mental fatigue could 
thus be at risk of being underdiagnosed 
with the CIS-f. In contrast fatigue in 
patients with little physical stamina and or 
many physical sequalea could be 
somewhat overstressed by using the CIS-f 
to diagnose post-stroke fatigue.  The 
addition of the CIS-subscale –
concentration might be used to capture 
mental fatigue, but caution is warranted 
since this may also reflect attention 
disorders which are common sequalea 
after stroke(Rasquin, Welter, & van 
Heugten, 2013).  
This study has some limitations. 
We assessed the psychometric properties 
of our scales by calculating internal 
consistency and convergent validity in 
patients with stroke and healthy controls. 
As we used a cross-sectional design, we 
were unable to examine the usefulness of 
the scales to detect changes over time (or 
treatment effects) in stroke patients. 
Furthermore, 35% of the included patients 
were part of the COGRAT study (Zedlitz, 
Rietveld, et al., 2012) in which only 
patients with a CIS-f score of 40 or above 
were included. Therefore, it is possible that 
the variability of our data was restricted 
and the generalizability compromised. 
However, the majority of patients were not 
selected on this basis and the standard 
deviations of patient scores were similar to 
those of healthy controls. This reduces the 
likelihood of such a bias. Another 
limitation concerns the inclusion of the 
other patient and the control group. These 
patients were not screened for depression, 
cognitive deficits or comorbid diseases, 
nor were these afflictions recorded. The 
same holds true for the healthy control 
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group. Therefore comorbid disease(s) or 
other confounding factors might have 
influenced our results. A more thorough 
screening might improve this.  
 
Conclusions 
 
Both the FSS7 and the subscale CIS-
fatigue show good internal consistency. 
However the convergent validity in stroke 
patients is only moderate, and factor 
analysis confirms that both scales measure 
different constructs. This means that they 
measure different aspects of fatigue and 
thus cannot be used interchangeably. In 
studies of fatigue severity, the CIS-f might 
be preferable over the FSS. The FSS is 
more suitable to assess the impact of 
fatigue on daily life. The FSS is shorter 
and easier to administer, whereas the CIS-
20r provides a multidimensional 
assessment not only of “Experienced 
fatigue” and “Physical condition” with the 
CIS-f subscale, but also of the influence of 
fatigue on “Concentration problems”, 
“Motivation” and “Activity” with the other 
subscales. The difference in the 
information provided must be taken into 
consideration when selecting a fatigue 
scale for either diagnostic and/or research 
purposes.  
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